MukoCell® – Advanced therapy medicinal products –
The MukoCell® procedure is an approved and established procedure in Germany. In Germany, more than 200 patients have already been treated with the MukoCell® procedure. The clinical data in a follow-up period of up to 36 months show that the procedure is safe and effective.
The MukoCell GmbH is a biotechnology company, headquartered in Dortmund / Germany, which specializes in the production, development and distribution of laboratory-produced patient-derived tissue substitutes for organ reconstruction.
The tissue substitute (MukoCell®), which originates from the company’s own research and development, is the world’s first tissue product (ATMP) in urology manufactured from the patient’s own cells. The advanced therapy medicinal product MukoCell® is an oral mucosal graft grown from the patient’s own cells for the reconstruction of the urethra.
MukoCell® is a gentle alternative to conventional transplantation with native oral mucosa. The tissue substitute, grown from the patient’s own cells, integrates into the surrounding tissue within a short time and develops into new, fully functional urethral tissue. More information on the topic Urethral stricture you can also find on Wikipedia.
MukoCell GmbH is exibitor at the Arab Health 2012 (Dubai, UAE) – booth ZD 51
Moderated Poster Session 12 – MP-12.04
Tissue- Engineered Buccal Mucosa Urethroplasty: Outcome of Our First Patients